Pharming Group Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	132.37	54.94	61.74	207.34	191.92	205.16
Short-Term Investments	33.8	112.95	151.68	-	-	-
Cash & Short-Term Investments	166.17	167.89	213.42	207.34	191.92	205.16
Cash Growth	-3.26%	-21.33%	2.93%	8.03%	-6.45%	175.94%
Accounts Receivable	43.61	41.53	35.41	20.96	18.08	23.51
Other Receivables	-	8.64	7.21	4.37	9.52	8.37
Receivables	43.61	50.17	42.62	25.33	27.59	31.88
Inventory	67.14	55.72	56.76	42.33	27.31	21.16
Prepaid Expenses	-	4.65	3.54	2.29	2.39	4.02
Restricted Cash	0.69	-	-	0.21	0.23	1
Total Current Assets	277.6	278.44	316.34	277.5	249.44	263.21
Property, Plant & Equipment	24.99	24.13	33.47	39.15	33.17	21.65
Long-Term Investments	6.67	4.23	10.4	9.73	8.65	7.12
Other Intangible Assets	134.93	61.04	71.27	74.87	83.57	88.63
Long-Term Deferred Tax Assets	27.49	30.54	29.76	22.97	21.22	31.88
Long-Term Deferred Charges	-	-	-	0.25	0.27	5.46
Other Long-Term Assets	2.11	1.6	1.62	1.33	1.01	0.51
Total Assets	473.79	399.99	462.85	425.8	397.32	418.45
Accounts Payable	78.22	10.1	16.02	8.75	7.6	13.47
Accrued Expenses	-	53.22	50.27	43.61	33.34	33.4
Current Portion of Long-Term Debt	5.21	4.25	1.82	1.77	1.88	2.04
Current Portion of Leases	4.48	2.95	3.62	3.47	2.42	1.96
Current Income Taxes Payable	-	3.28	6.23	2.1	1.51	0.62
Other Current Liabilities	-0	-	-	-	0.03	25.36
Total Current Liabilities	87.91	73.8	77.97	59.7	46.77	76.85
Long-Term Debt	93.14	78.15	136.6	131.62	139.01	149.73
Long-Term Leases	28.09	26.97	29.51	29.84	18.46	8.23
Other Long-Term Liabilities	-0	-	-	-	0.17	0.21
Total Liabilities	209.14	178.92	244.07	221.16	204.4	235.02
Common Stock	7.95	7.77	7.67	7.51	7.43	7.31
Additional Paid-In Capital	507.72	488.99	478.43	462.3	455.25	447.13
Retained Earnings	-276.88	-287.92	-265.5	-265.17	-269.77	-271.01
Comprehensive Income & Other	25.85	12.23	-1.82	-	-	-
Shareholders' Equity	264.64	221.06	218.78	204.64	192.92	183.44
Total Liabilities & Equity	473.79	399.99	462.85	425.8	397.32	418.45
Total Debt	130.92	112.31	171.55	166.69	161.76	161.96
Net Cash (Debt)	35.25	55.58	41.88	40.65	30.16	43.2
Net Cash Growth	-21.12%	32.72%	3.03%	34.76%	-30.18%	167.52%
Net Cash Per Share	0.06	0.08	0.06	0.06	0.04	0.06
Filing Date Shares Outstanding	502.26	683.93	673.44	656.35	648.75	641.29
Total Common Shares Outstanding	502.26	680.31	671.07	656.35	648.75	638.82
Working Capital	189.69	204.64	238.37	217.8	202.67	186.36
Book Value Per Share	0.53	0.32	0.33	0.31	0.30	0.29
Tangible Book Value	129.72	160.02	147.51	129.77	109.35	94.81
Tangible Book Value Per Share	0.26	0.24	0.22	0.20	0.17	0.15
Land	-	-	-	-	0.03	0.03
Machinery	-	9.3	9.66	8.28	14.84	6.59
Construction In Progress	-	0.15	0.18	0.01	0.62	2.87
Leasehold Improvements	-	5.43	5.55	5.28	5.71	2.48

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q